SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-053925
Filing Date
2020-10-05
Accepted
2020-10-05 20:31:44
Documents
1
Period of Report
2020-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5312
  Complete submission text file 0001209191-20-053925.txt   6803
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RETROPHIN, INC. 3721 VALLEY CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Heerma Peter (Reporting) CIK: 0001789617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 201225270